PP
EW icon

Paloma Partners’s Edwards Lifesciences EW Stock Holding History

Paloma Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,800
Closed -$2.76M – 545
2024
Q3 		$2.76M Buy
+41,800
New +$3.04M 0.08% 226
2024
Q1 		– Sell
-74,300
Closed -$5.67M – 873
2023
Q4 		$5.67M Buy
+74,300
New +$5.17M 0.21% 101
2023
Q2 		– Sell
-7,900
Closed -$654K – 818
2023
Q1 		$654K Sell
7,900
-21,600
-73% -$1.7M 0.02% 443
2022
Q4 		$2.2M Buy
29,500
+14,200
+93% +$1.09M 0.1% 197
2022
Q3 		$1.26M Sell
15,300
-8,200
-35% -$789K 0.06% 266
2022
Q2 		$2.23M Buy
+23,500
New +$2.43M 0.08% 247

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Paloma Partners's EW Position: Q2 2025 in Review

Paloma Partners sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 4,776 shares — an estimated $346K sold.

Paloma Partners first reported a position in EW in Q4 2013 and held it in 39 quarters. The position peaked at $37.9M in Q2 2019. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Paloma Partners reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 4,776 Edwards Lifesciences shares in Q2 2025, an estimated $346K.
  • Paloma Partners first reported a position in Edwards Lifesciences in Q4 2013 and held it in 39 quarters.
  • Paloma Partners's Edwards Lifesciences position peaked at $37.9M in Q2 2019.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.